| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | ACUR Acura Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 50,000 | 0.00 | 545,503 |
| 2 Jan 25 | ACUR Acura Pharmaceuticals | RSU Common Stock | Grant | Dispose A | No | No | 0 | 50,000 | 0.00 | 50,000 |
| 2 Jan 25 | ACUR Acura Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 50,000 | 0.00 | 0 |
| 2 Jan 24 | ACUR Acura Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 50,000 | 0.00 | 495,503 |
| 2 Jan 24 | ACUR Acura Pharmaceuticals | RSU Common Stock | Grant | Dispose A | No | No | 0 | 50,000 | 0.00 | 50,000 |
| 2 Jan 24 | ACUR Acura Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 50,000 | 0.00 | 0 |
